The U.S. Department of Health and Human Services’ Office of the Assistant Secretary for Preparedness and Response’s Biomedical Advanced Research and Development Authority (BARDA) awards a two-year $19.7M contract to Emergent Biosystems (NYSE:EBS) to develop and manufacture cGMP (current good manufacturing practice) lots of three Ebola monoclonal antibodies in CHO (Chinese hamster ovary) cell lines at a scale of 2,000 liters.
{iframe}http://seekingalpha.com/news/2637625-emergent-bio-snags-20m-barda-contract-for-ebola-mabs#email_link{/iframe}